Vertos raises $15.5M to decompress spines
Vertos Medical, maker of a non-invasive device for decompressing lumbar spine discs, has brought in $15.5 million in a fourth round of funding from Onset Ventures, CHL Medical Partners, Foundation Medical Partners, Aweida Venture Partners and DFJ Mercury. Based in Aliso Viejo, Calif., the company has now raised $32.5 million to date.
Direct Flow Medical takes $40M for heart valve treatments
Direct Flow Medical, maker of a minimally-invasive device to treat heart valve disease, has raised $40 million of a targeted $42.5 million third round of venture funding, according to a filing with the SEC. Based in Santa Rosa, Calif., the company is backed by Johnson & Johnson Development Corp., Foundation Medical Partners, VantagePoint Venture Partners, ePlanet Ventures, EDF Ventures, New Leaf Venture Partners and Spray Venture Partners. It has raised $75 million to date.
Life-science briefing: Friday, April 4, 2008
TODAY’S HEADLINES:
IlluminOss Medical gets $11M for bone-fracture devices (peHUB)
Contract researcher Crown Bioscience takes in funding (release)
IlluminOss Medical gets $11M for bone-fracture devices — East Providence, R.I.-based IlluminOss Medical, a medical-device startup, raised $11 million in a second funding round, peHUB reports. Backers included New Leaf Ventures and Foundation Medical Partners.
The company’s Web site is barely more than a stub that describes IlluminOss as a device company “pioneering new frontiers in orthopedic surgery.” peHUB offers the… Continue Reading
Life sciences briefing: Tuesday, Dec. 4, 2007
Featured companies: AgraQuest, BridgeHealth, CardioMems, Collegium Pharmaceutical, Emergin, Entegrion, gDiapers, Precision Therapeutics, PregLem
UPDATED: Expanded items on Entegrion, Collegium, and gDiapers. Added CardioMems item. New items posted on AgraQuest (link), BridgeHealth (link) and Precision Therapeutics (link).
Entegrion draws $4.7M for bleeding control — Entegrion, a Research Triangle Park, N.C., biotech focused on products that stop bleeding, raised $4.7 million in a second funding round, VentureWire reports (subscription req’d). Investors included BD Ventures, Catalysta Partners and unnamed individuals.
Entegrion’s main product… Continue Reading
Life sciences briefing: Friday, Oct. 19, 2007
Featured companies: DirectFlow, Direvo, Indigo Biosystems, MacroGenics
Direct Flow raises $27M for heart-valve implants — Santa Rosa, Calif.-based Direct Flow Medical, a startup developing heart implants, raised $27 million in a second funding round. Investors included Johnson & Johnson Development, Foundation Medical Partners, VantagePoint Venture Partners, ePlanet, EDF Ventures, New Leaf Venture Partners and Spray Venture Partners.
Direct Flow makes minimally invasive aortic-valve replacements for the heart. This particular field happens to be booming — we’ve previously covered… Continue Reading
Life sciences briefing: Wednesday, Aug. 29, 2007
(UPDATED at 3:10pm PT: See below.)
Featured companies: Agendia, EndoGastric Solutions, FlowCo, Gentris, MedManage Systems, ParagonDx, Presidio Pharmaceuticals, Xoova
Presidio Pharma raises $26M for viral treatments — San Francisco’s Presidio Pharmaceuticals, a biotech developing new antiviral drugs, raised $26 million in a second funding round. Investors included Panorama Capital, Baker Brothers Investments, Bay City Capital, Ventures West Capital, Nexus Medical Partners, Sagamore Bioventures, George Rathmann Fund and Peninsula Overview Partners.
Presidio’s lead drug candidates take aim at HIV, hepatitis… Continue Reading
Neuromodulator Innovative Metabolics picks up $5.5M
Innovative Metabolics, a Boston developer of neuromodulation systems for “chronic disease,” raised $5.5 million in a first funding round, VentureWire reports (subscription required). The round was led by Morgenthaler Ventures, which was joined by Foundation Medical Partners.
Although the company apparently still wants to keep a low profile, it’s not too hard to make an educated guess at what it might be up to. In January, Innovative Metabolics paid $500,000 and an unspecified number of preferred… Continue Reading
NeuroVista raises $33.8M for epilepsy devices
(CORRECTED: See below.)
Seattle-based NeuroVista, a developer of devices for the treatment of epilepsy, raised $33.8 million in a second-round funding and left behind its former name, BioNeuronics.
The company, founded in 2002 by whiz kid Daniel DiLorenzo, has been quiet about its technology and commercial direction. In April, however, DiLorenzo received a patent for a “neurological control system” using “closed-loop intracranial stimulation” for the “optimal control of neurological disease.” In other words, given NeuroVista’s public interest in… Continue Reading
Coapt Systems, maker of aesthetic surgery implants, raises $22.6M more
Coapt Systems, a Palo Alto, Ca. maker of bioabsorbable implants for use in aesthetic surgery, has raised $22.6 million in a fifth funding.
The round, led by Global Life Science Ventures and Easton Capital, included existing investors Alta Partners, Asset Management Company, Canaan Partners, Boston Millennia Partners, and Foundation Medical Partners.
Coapt Systems, founded in 2000, has developed implantable soft tissue fixation devices for use in facial plastic surgery. The company’s pipeline also includes a hand… Continue Reading